Leading the charge: Tackling tuberculosis and other diseases with mRNA
Monash’s Institute of Pharmaceutical Sciences groundbreaking work on Australia’s first mRNA COVID-19 vaccine and, now, a new mRNA-LNP vaccine for tuberculosis, is positioning Australia as a leader in addressing global health challenges.